Free tool
FAERS Monitor: Soaanz
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 213218 or its brand name (Soaanz, Torsemide). Reports on generic versions are filed under their own applications.
Reports
33,936
Serious
27,263
80% of reports
Hospitalization
18,163
Death reported
4,525
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea3,621
- fatigue2,261
- diarrhoea2,143
- nausea2,119
- dizziness2,004
- acute kidney injury1,817
- death1,768
- general physical health deterioration1,689
- fall1,676
- oedema peripheral1,628
- headache1,597
- hypotension1,545
- anaemia1,478
- cardiac failure1,406
- pneumonia1,395
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 224 |
| 2005 | 282 |
| 2006 | 323 |
| 2007 | 327 |
| 2008 | 410 |
| 2009 | 521 |
| 2010 | 572 |
| 2011 | 821 |
| 2012 | 975 |
| 2013 | 404 |
| 2014 | 550 |
| 2015 | 848 |
| 2016 | 1,256 |
| 2017 | 1,175 |
| 2018 | 1,481 |
| 2019 | 1,745 |
| 2020 | 1,934 |
| 2021 | 2,830 |
| 2022 | 4,327 |
| 2023 | 3,026 |
| 2024 | 3,598 |
| 2025 | 3,685 |
| 2026 | 2,622 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,020,223 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| cardiac failureSignal | 1,406 | 11.0 | 10.5 | 12,638 |
| general physical health deteriorationSignal | 1,689 | 9.2 | 8.7 | 12,168 |
| oedema peripheralSignal | 1,628 | 8.4 | 8.0 | 10,487 |
| acute kidney injurySignal | 1,817 | 7.4 | 7.1 | 10,067 |
| anaemiaSignal | 1,478 | 4.8 | 4.6 | 4,495 |
| hypotensionSignal | 1,545 | 4.8 | 4.6 | 4,657 |
| dyspnoeaSignal | 3,621 | 4.0 | 3.9 | 8,259 |
| fallSignal | 1,676 | 3.1 | 3.0 | 2,457 |
| pneumoniaSignal | 1,395 | 2.7 | 2.5 | 1,481 |
| dizzinessSignal | 2,004 | 2.5 | 2.4 | 1,832 |
| diarrhoeaSignal | 2,143 | 2.1 | 2.0 | 1,203 |
| fatigue | 2,261 | 1.8 | 1.7 | 835 |
| nausea | 2,119 | 1.7 | 1.6 | 577 |
| headache | 1,597 | 1.6 | 1.5 | 349 |
| death | 1,768 | 1.3 | 1.2 | 107 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.